“…Although systemic inflammatory response syndrome (SIRS) and uncontrolled hyperinflammation have attracted considerable interest as a pathway mediating multiple organ dysfunction of the surgical patient, recent evidence suggests that an overwhelming release of anti-inflammatory mediators and decreased production of pro-inflammatory mediators, most notably TNF-α, may propagate the development of MOF in the late course of sepsis [3,5,17]. Consistent with this concept, several studies have provided evidence that an impaired release of TNF-α by whole blood obtained from patients on in vitro LPS stimulation is associated with a poor outcome [5,10,17,23], while recovery of the LPS-stimulated TNF-α response is an indicator of survival/recovery in severely septic patients [5,10,23]. Typically, these patients require long-term treatment in intensive care units (ICU) including continuous administration of sedatives and analgesics.…”